Filing Details
- Accession Number:
- 0001437749-17-016405
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-09-27 16:54:52
- Reporting Period:
- 2017-09-25
- Accepted Time:
- 2017-09-27 16:54:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1427925 | Acelrx Pharmaceuticals Inc | ACRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1511368 | G Lawrence Hamel | C/O Acelrx Pharmaceuticals, Inc. 351 Galveston Drive Redwood City CA 94063 | Chief Development Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-09-25 | 13,827 | $0.00 | 68,504 | No | 4 | S | Indirect | See footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See footnote |
Footnotes
- 52,125 of the Shares are held in the Hamel Revocable Living Trust
- The Shares were sold in a range from $3.50-$4.50
- Non-reportable acquisition of 1,977 shares of Common Stock through the Company's Employee Stock Purchase Plan
Billionaire Hedge Funds
